33 / 154
359
grade II–III diffuse gliomas. Acta Neuropathol 2015; 129:585–
596.
23. Reuss DE, Mamatjan Y, Schrimpf D et al. IDH mutant diffuse
and anaplastic astrocytomas have similar age at presentation
and little difference in survival: a grading problem for WHO.
Acta Neuropathol 2015; 129:867–873.
24. Ohgaki H, Kleihues P. The definition of primary and secondary
glioblastoma. Clin Cancer Res 2013; 19:764–772.
25. Parsons DW, Jones S, Zhang X, et al. An integrated
genomic
analysis
of
human
glioblastoma
multiforme.
Science.
2008;321(5897):1807–12.
26. Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling
A. Monoclonal antibody specific for IDH1 R132H mutation.
Acta Neuropathol. 2009;118(5):599–601.
27. Felsberg J, Wolter M, Seul H, et al. Rapid and sensitive
assessment of the IDH1 and IDH2 mutation status in cerebral
glio- mas based on DNA pyrosequencing. Acta Neuropathol.
2010;119(4):501–7.
28. Pearson BE, Markert JM, Fisher WS, Guthrie BL, Fiveash JB,
Palmer CA, et al. Hitting a moving target: evolution of a
treatment paradigm for atypical meningiomas amid changing
diagnostic criteria. Neurosurgical focus. 2008;24(5):E3.
29. Campbell BA, Jhamb A, Maguire JA, et al. Meningiomas in
2009: controversies and future challenges. Am J Clin Oncol
2009;32:73–85.
30. Marcus HJ, Price SJ, Wilby M, et al. Radiotherapy as an
adjuvant in the management of intracranial meningiomas:
are we practising evidence-based medicine? Br J Neurosurg
2008;22:520–8.
31. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. World Health
Organization histological classification of tumours of the
central nervous system. International Agency for Research on
cancer, Lyon 2007.
32. EllisonDW,KocakM,Figarella-BrangerDetal.Histopathological
grading of pediatric ependymoma: reproducibility and clinical
relevance in European trial cohorts. J Negat Results Biomed
2011; 10:7. doi:10.1186/1477-5751-10-7.
33. Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dal-
ton JD, Li Y, et al. C11orf95-RELA fusions drive oncogenic
NF-kappaB signalling in ependymoma. Nature 2014;
506:451–455. doi:10.1038/nature13109.
34. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford
SC, et al. Molecular subgroups of medulloblastoma: the cur-
rent consensus. Acta Neuropathol 2012; 123:465–472.
doi:10.1007/ s00401-011-0922-z .
[NEUROPATOLOGÍA: DIAGNÓSTICO CON BIOLOGÍA MOLECULAR - Dr. Facundo Las Heras MD PhD y col.]